Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.48 |
| ▸ | FDPS | P14324 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8958161 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL11042226 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL3650845 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL9846062 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL5870036 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL19820393 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL20047630 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL8536232 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL10608827 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 | |
| SCHEMBL14840109 | 1.00 | SMPD1 (0.48) | SMPD1FDPSTSHRTHRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115991633-B | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2024-06-25 | — | — | CN | claimed |
| CN-115991633-A | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2023-04-21 | — | — | CN | claimed |
| CN-115991633-B | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2024-06-25 | — | — | CN | disclosed |
| US-11800792-B2 | Organic compound with spirocyclic adamantane, and electronic element and electronic device using same | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-24 | — | — | US | disclosed |
| US-20230285378-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230200215-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| CN-115991633-A | Method for preparing methanol and ethylene glycol and co-producing formic acid by photocatalysis of polyalcohol | 中国科学院大连化学物理研究所 | 2023-04-21 | — | — | CN | disclosed |
| US-20230052660-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-02-16 | — | — | US | disclosed |
| US-20230031954-A1 | TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT | TETRAPHASE PHARMACEUTICALS, INC. | 2023-02-02 | — | — | US | disclosed |
| US-20220168435-A1 | PROGRAMMABLE POLYMERIC DRUGS | SONY CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20220073496-A1 | NOVEL QUINOLINE DERIVATIVE INHIBITOR | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2022-03-10 | — | — | US | disclosed |
| US-20170216445-A1 | CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-03 | — | — | US | disclosed |
| US-9593444-B2 | Method for producing sizing agent-coated carbon fibers, and sizing agent-coated carbon fibers | TORAY INDUSTRIES, INC. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-9586978-B2 | Anti-viral compounds | ABBVIE INC. (US) | 2017-03-07 | — | — | US | disclosed |
| US-20160230332-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES, INC. (JP) | 2016-08-11 | — | — | US | disclosed |
| US-9249295-B2 | Carbon fiber-reinforced thermoplastic resin composition, molding material, prepreg, and methods for producing same | TORAY INDUSTRIES, INC. (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20140228519-A1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME | TORAY INDUSTRIES, INC. (JP) | 2014-08-14 | — | — | US | disclosed |
| EP-2765155-A1 | CARBON FIBER-REINFORCED THERMOPLASTIC RESIN COMPOSITION, MOLDING MATERIAL, PREPREG, AND METHODS FOR PRODUCING SAME | Toray Industries, Inc. (JP) | 2014-08-13 | — | — | EP | disclosed |
| EP-2589701-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | Toray Industries, Inc. (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-20130089736-A1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES, INC. (JP) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220073496-A1 | NOVEL QUINOLINE DERIVATIVE INHIBITOR | CSF1R, CSF3R, FLT3 | SMPD1 2781/4885FDPS 2689/4885TSHR 582/4885 |
| US-11800792-B2 | Organic compound with spirocyclic adamantane, and electronic element and electronic device using same | OR51E2, SQLE, ODC1 | SMPD1 617/4885FDPS 182/4885TSHR 4238/4885 |
| US-20230285378-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | SMPD1 2779/4885FDPS 211/4885TSHR 4834/4885 |
| US-20230052660-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NOD1, NFE2L2, NOTCH1 | SMPD1 4883/4885FDPS 1525/4885TSHR 4512/4885 |
| US-20230200215-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | LEF1, OCIAD1, OR10J3 | SMPD1 3204/4885FDPS 566/4885TSHR 4727/4885 |
| US-20230031954-A1 | TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT | MCL1, ABL1, MALT1 | SMPD1 508/4885FDPS 4001/4885TSHR 1458/4885 |
| US-20170216445-A1 | CXCR4 INHIBITING CARRIERS FOR NUCLEIC ACID DELIVERY | CXCL12, CXCR4, CXCR2 | SMPD1 1516/4885FDPS 3641/4885TSHR 2110/4885 |
| US-20220168435-A1 | PROGRAMMABLE POLYMERIC DRUGS | CHRM1, PBRM1, CHRM2 | SMPD1 2886/4885FDPS 3745/4885TSHR 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.